Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Interstitial Pneumonias”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Not applicableEnded earlyNCT02821039
What this trial is testing

Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study

Who this might be right for
Idiopathic Pulmonary FibrosisUsual Interstitial Pneumonia
Turkish Thoracic Society 1,678
Not applicableLooking for participantsNCT06036719
What this trial is testing

Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives

Who this might be right for
Interstitial Lung Diseases
Institut National de la Santé Et de la Recherche Médicale, France 3,000
Not applicableStudy completedNCT04481074
What this trial is testing

Inspiratory Muscle Training in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial FibrosisPulmonary DiseaseInterstitial Lung Disease+3 more
Federal University of Minas Gerais 14
Very early researchActive Not RecruitingNCT05365802
What this trial is testing

FAPI PET for Lung Fibrosis

Who this might be right for
Interstitial Lung DiseaseIdiopathic Interstitial PneumoniasDrug-Induced Pneumonitis+4 more
University of California, Los Angeles 30
Not applicableStudy completedNCT01110694
What this trial is testing

Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study

Who this might be right for
Idiopathic Pulmonary FibrosisIdiopathic Non-specific Interstitial Pneumonitis
Royal Brompton & Harefield NHS Foundation Trust 230
Testing effectiveness (Phase 2)UnknownNCT05246293
What this trial is testing

Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
National Institute of Respiratory Diseases, Mexico 60
Not applicableUnknownNCT02827734
What this trial is testing

Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

Who this might be right for
Pulmonary Healthy ControlsInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+3 more
Universitätsmedizin Mannheim 50
Testing effectiveness (Phase 2)Ended earlyNCT02138825
What this trial is testing

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

Who this might be right for
Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Bayer 147
Not applicableLooking for participantsNCT06702228
What this trial is testing

Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland

Who this might be right for
Connective Tissue DiseasesInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+3 more
Royal College of Surgeons, Ireland 300
Testing effectiveness (Phase 2)Study completedNCT02594839
What this trial is testing

Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease

Who this might be right for
Idiopathic Interstitial PneumoniaInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 20
Not applicableStudy completedNCT01624753
What this trial is testing

Fibered Confocal Fluorescence Microscopy Imaging in Patients With Diffuse Parenchymal Lung Diseases

Who this might be right for
Diffuse Parenchymal Lung Diseases
Singapore General Hospital 27
Large-scale testing (Phase 3)Ended earlyNCT03955146
What this trial is testing

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kyntra Bio 393
Not applicableStudy completedNCT01961362
What this trial is testing

Supplemental Oxygen in Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
National Jewish Health 19
Not applicableStudy completedNCT04430491
What this trial is testing

To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisUsual Interstitial Pneumonia
Maastricht University 300
Testing effectiveness (Phase 2)Study completedNCT00189176
What this trial is testing

Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Michigan 23
Early research (Phase 1)Study completedNCT06160440
What this trial is testing

The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

Who this might be right for
Diopathic Pulmonary FibrosisPulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 55
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Post-approval studies (Phase 4)UnknownNCT00637065
What this trial is testing

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+1 more
Royal Brompton & Harefield NHS Foundation Trust 48
Large-scale testing (Phase 3)Ended earlyNCT04419558
What this trial is testing

Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kyntra Bio 372
Not applicableActive Not RecruitingNCT07577115
What this trial is testing

Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases.

Who this might be right for
Interstitial Lung Disease Due to Systemic Disease (Disorder)Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder)Exposure Occupational+10 more
Istituto Clinico Humanitas 1,000
Next Page